Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV000487779 | SCV000574785 | uncertain significance | not provided | 2016-09-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001083044 | SCV001096891 | likely benign | Developmental and epileptic encephalopathy, 32 | 2023-12-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000487779 | SCV001890705 | benign | not provided | 2020-04-16 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002404274 | SCV002704158 | likely benign | Inborn genetic diseases | 2017-06-07 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV004551595 | SCV004780706 | likely benign | KCNA2-related disorder | 2023-12-21 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |